BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2612015)

  • 1. Prolactinomas presenting as primary amenorrhoea and delayed or arrested puberty: response to medical therapy.
    Howlett TA; Wass JA; Grossman A; Plowman PN; Charlesworth M; Touzel R; Rees LH; Savage MO; Besser GM
    Clin Endocrinol (Oxf); 1989 Feb; 30(2):131-40. PubMed ID: 2612015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin-secreting macroadenomas in adolescents. Response to bromocriptine therapy.
    Tyson D; Reggiardo D; Sklar C; David R
    Am J Dis Child; 1993 Oct; 147(10):1057-61. PubMed ID: 8213676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromocriptine treatment of seven women with primary amenorrhoea and prolactin-secreting pituitary tumours.
    Bergh T; Nillius SJ; Wide L
    Clin Endocrinol (Oxf); 1979 Feb; 10(2):145-54. PubMed ID: 570900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperprolactinaemia in males: a heterogeneous disorder.
    Walsh JP; Pullan PT
    Aust N Z J Med; 1997 Aug; 27(4):385-90. PubMed ID: 9448878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long-term effects of megavoltage radiotherapy as sole or combined therapy for large prolactinomas: studies with high definition computerized tomography.
    Johnston DG; Hall K; Kendall-Taylor P; Ross WM; Crombie AL; Cook DB; Watson MJ
    Clin Endocrinol (Oxf); 1986 Jun; 24(6):675-85. PubMed ID: 3098457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactinomas in children and adolescents. Clinical presentation and long-term follow-up.
    Colao A; Loche S; Cappa M; Di Sarno A; Landi ML; Sarnacchiaro F; Facciolli G; Lombardi G
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2777-80. PubMed ID: 9709946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid resolution of visual abnormalities with medical therapy alone in patients with large prolactinomas.
    Mbanya JC; Mendelow AD; Crawford PJ; Hall K; Dewar JH; Kendall-Taylor P
    Br J Neurosurg; 1993; 7(5):519-27. PubMed ID: 8267889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and drug therapy of prolactinoma.
    Ciccarelli E; Camanni F
    Drugs; 1996 Jun; 51(6):954-65. PubMed ID: 8736617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of hyperprolactinaemic amenorrhoea.
    Franks S; Jacobs HS; Hull MG; Steele SJ; Nabarro JD
    Br J Obstet Gynaecol; 1977 Apr; 84(4):241-53. PubMed ID: 870009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperprolactinaemia and pituitary adenomas in adolescence.
    Dissaneevate P; Warne GL
    J Pediatr Endocrinol Metab; 1998; 11(4):531-41. PubMed ID: 9777574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of prolactin-secreting macroadenomas with parenteral, long-acting bromocriptine in 30 patients treated for up to 3 years.
    Haase R; Jaspers C; Schulte HM; Lancranja I; Pfingsten H; Orri-Fend M; Reinwein D; Benker G
    Clin Endocrinol (Oxf); 1993 Feb; 38(2):165-76. PubMed ID: 8435897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors in the outcome of transsphenoidal surgery for prolactinoma and non-functioning pituitary tumour, including pre-operative bromocriptine therapy.
    Bevan JS; Adams CB; Burke CW; Morton KE; Molyneux AJ; Moore RA; Esiri MM
    Clin Endocrinol (Oxf); 1987 May; 26(5):541-56. PubMed ID: 3665118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Giant prolactinomas larger than 60 mm in size: a cohort of massive and aggressive prolactin-secreting pituitary adenomas.
    Shimon I; Sosa E; Mendoza V; Greenman Y; Tirosh A; Espinosa E; Popovic V; Glezer A; Bronstein MD; Mercado M
    Pituitary; 2016 Aug; 19(4):429-36. PubMed ID: 27138902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case].
    Pasinetti E; Schivardi MR; Falsetti L; Gastaldi A
    Minerva Ginecol; 1989 Mar; 41(3):157-60. PubMed ID: 2666885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of a long-acting injectable form of bromocriptine in patients with prolactin and growth hormone secreting macroadenomas.
    Tsagarakis S; Tsiganou E; Tzavara I; Nikolou H; Thalassinos N
    Clin Endocrinol (Oxf); 1995 Jun; 42(6):593-9. PubMed ID: 7634499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of the therapeutic results of bromocriptine treatment of prolactin microadenoma and macroadenoma].
    Jin ZM; Shi YF; Chen GL
    Zhonghua Nei Ke Za Zhi; 1990 Nov; 29(11):669-72, 702-3. PubMed ID: 2086009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of pituitary-tumour size in patients with prolactinomas and acromegaly treated with bromocriptine with or without radiotherapy.
    Wass JA; Moult PJ; Thorner MO; Dacie JE; Charlesworth M; Jones AE; Besser GM
    Lancet; 1979 Jul; 2(8133):66-9. PubMed ID: 87966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prolactin-producing pituitary adenomas as a cause of primary amenorrhea and their neurosurgical treatment].
    Landolt AM
    Dtsch Med Wochenschr; 1983 Feb; 108(8):298-301. PubMed ID: 6825603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperprolactinemia. Long-term effects of bromocriptine.
    Johnston DG; Prescott RW; Kendall-Taylor P; Hall K; Crombie AL; Hall R; McGregor A; Watson MJ; Cook DB
    Am J Med; 1983 Nov; 75(5):868-74. PubMed ID: 6638052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demographic characteristics, presentations and treatment outcome of patients with prolactinoma.
    Malik S; Hussain SZ; Basit R; Idress N; Habib A; Zamant M; Islam N
    J Ayub Med Coll Abbottabad; 2014; 26(3):269-74. PubMed ID: 25671924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.